德克斯作为抗凝剂和抗血小板剂:范围审查协议
Ariane Flinkier1, Suwandi Dewapura1, Hai Tran1
1Department of Anaesthesia, Austin Health, Heidelberg, Victoria, Australia.
BMJ open
|June 30, 2025
概括
本范围审查审查检查了德克斯.
科学领域:
- 在外科手术期间的医学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 血液静止对于手术结果至关重要,但由于可变的血栓预防方案和抗血小板抵抗,它面临着挑战.
- 德克斯,具有血静性质的多糖,在各种手术环境中具有潜在的应用,但缺乏标准化的临床指南.
- 现有的文献质量令人担忧,阻碍了德克斯兰斯在临床实践中的最佳整合.
研究的目的:
- 进行对同行评审和灰色文献关于使用德克斯治疗血液静止的范围审查.
- 分析和绘制现有关于手术和非手术环境中的德克斯指示,疗效和并发症的现有研究.
- 识别知识缺口并指导未来关于德克斯临床应用的研究.
主要方法:
- 按照PRISMA-ScR标准进行系统的文献搜索.
- 包括在2024年3月11日之前发表的研究,来自EMBASE,Cochrane图书馆和MEDLINE等数据库.
- 两位研究人员使用混合方法和叙事方法对发现的描述性陈述.
主要成果:
- 数据选和提取正在进行中.
- 将对德克斯在血液静止中的作用进行全面分析.
结论:
- 这一审查将提供关于德克斯在血液静止中使用的当前证据基础的见解.
- 结果将为临床实践提供信息,并突出未来研究领域,以标准化德克斯的应用.
相关概念视频
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
921
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
921
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
653
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
653
Venous Thrombosis III: Interprofessional Care
27
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
27
Cardiovascular Drugs: Classification based on Therapeutic Indications
3.2K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.2K
Coronary Artery Disease V: Interprofessional Care
39
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
39


